NASDAQ: AHCOAdapthealth Corp Stock
$9.70+0.04 (+0.41%)
Updated Jun 23, 2026
AHCO Price
$9.70
Fair Value Price
N/A
Market Cap
$1.32B
52 Week Low
$8.51
52 Week High
$13.43
P/E
-16.44x
P/B
0.88x
P/S
0.49x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.29B
Earnings
-$79.63M
Gross Margin
18.3%
Operating Margin
2.07%
Profit Margin
-2.4%
Debt to Equity
1.93
Operating Cash Flow
$600M
Beta
1.02
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
AHCO Overview
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AHCO's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
AHCO
Ranked#20 of 93
Ranked#20 of 93
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.29 | A | |
| $38.53 | A | |
| $26.45 | A |
Be the first to know about important AHCO news, forecast changes, insider trades & much more!
AHCO News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AHCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AHCO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AHCO is good value based on its book value relative to its share price (0.88x), compared to the US Medical Devices industry average (2.96x)
P/B vs Industry Valuation
AHCO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AHCO due diligence checks available for Premium users.
Valuation
AHCO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-16.44x
Industry
20.37x
Market
7.68x
AHCO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.88x
Industry
2.96x
AHCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AHCO's financial health
Profit margin
Revenue
$819.8M
Net Income
-$16.0M
Profit Margin
-2%
AHCO's Earnings (EBIT) of $68.12M... subscribe to Premium to read more.
Interest Coverage Financials
AHCO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.4B
Liabilities
$2.9B
Debt to equity
1.93
AHCO's short-term liabilities ($743.29M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHCO's long-term liabilities ($2.17B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHCO's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
AHCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$93.7M
Investing
-$204.5M
Financing
$52.6M
AHCO's operating cash flow ($599.97M)... subscribe to Premium to read more.
Debt Coverage Financials
AHCO vs Medical Device Stocks
Adapthealth Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.